Delivery System for Probiotics Awarded US Patent
This new US patent is in addition to four international patents already awarded to Nutraceutix for BIO-tract in China, Australia, Russia and Singapore.
Oct 7 2011 --- The United States Patent Office has issued Nutraceutix, Inc. Patent No. 8,007,777 "Delivery System For Biological Component" for BIO-tract dietary supplements containing probiotics. This new US patent is in addition to four international patents already awarded to Nutraceutix for BIO-tract in China, Australia, Russia and Singapore. Several related patents are still pending.
Unlike powders, capsules and cultured foods, BIO-tract tablets protect probiotics from damaging stomach acids, then gently release live organisms over time to the upper and lower intestinal tracts for optimal effectiveness. BIO-tract not only offers effective delivery for any probiotic organism, but takes advantage of the company's patented LiveBac process to extend probiotic shelf life far beyond other supplement forms, even at room temperature.
"Securing this US patent is the result of a lengthy, rigorous process and asserts what we've known for quite some time: BIO-tract caplets with LiveBac processing are unparalleled when it comes to the effective delivery of live probiotic organisms to the body," explains Tim Gamble, President and CEO of Nutraceutix. "No other probiotic dietary supplement format offers the outstanding combination of advantages and formulation flexibility that BIO-tract provides."
